So, a new “conspiracy theory” has emerged after the notorious Will Smith slapped hard comedian Chris Rock.
But, it was not a case of coincidence, as it appears.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
Right now there’s a race between several pharma companies to be the first to get an FDA-approved alopecia drug on the market.
There are currently no FDA-approved treatments for alopecia, an autoimmune disease characterized by hair loss, but multiple drugs could come to market in the indication over the coming years.
The entire world is now talking about alopecia, thanks to the “slap” that happened at the Oscars between Will Smith and Chris Rock.
And that’s thanks to no one else but Will Smith.
“Pfizer completed their acquisition of clinical-stage pharma company “Arena Pharma,” which specializes in alopecia studies, among other things,” Pharma Biz reported about a week ago.
“Arena Pharmaceuticals brings to Pfizer a portfolio of diverse and promising development-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently in development for a range of immuno-inflammatory diseases including ulcerative colitis, Crohn’s disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata.”
“Pfizer and BioNTech are proud to support the Oscars, and we are heartened to see the film industry gather in person and alongside fans to celebrate the talent and artistry produced during the past year,” a Pfizer spokesperson told Fierce Pharma Marketing.
In the phase 2b/3 ALLEGRO trial, JAK inhibitor ritlecitinib hit its primary objective of improving the area of scalp covered by hair in people with this autoimmune form of hair loss, giving Pfizer a positive readout in the first of two trials that will form the basis of regulatory filings for the drug.
What would you say about this?